ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,121Medicare Part D Prescriptions Filled, Including Refills

Rank: 60 out of 944

$791K Total Retail Price of All Prescriptions

Rank: 40 out of 944

550 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 550 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

14% of this provider’s 550 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,269 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 487 459 1 2
OMEPRAZOLE 486 455 2 4
FUROSEMIDE 456 455 3 6
HYDROCODONE-ACETAMINOPHEN 452 408 S3 4 10
AMLODIPINE BESYLATE 437 421 5 5
LISINOPRIL 363 354 6 3
SIMVASTATIN 336 313 7 1
WARFARIN SODIUM 286 274 8 7
POTASSIUM CHLORIDE 234 225 9 15
METOPROLOL TARTRATE 229 219 10 8
ATORVASTATIN CALCIUM 223 211 11 13
DONEPEZIL HCL 216 208 12 24
NAMENDA 214 214 13 37
METOPROLOL SUCCINATE 211 206 14 14
PRAVASTATIN SODIUM 208 189 15 17
TRAMADOL HCL 192 170 16 21
METFORMIN HCL 190 169 17 12
HYDROCHLOROTHIAZIDE 181 171 18 9
CITALOPRAM HBR 181 169 18 19
SERTRALINE HCL 174 153 20 23
LOSARTAN POTASSIUM 153 149 21 16
BENAZEPRIL HCL 150 136 22 66
GLIMEPIRIDE 150 143 22 47
CRESTOR 127 100 24 28
ALLOPURINOL 114 102 25 22
CYMBALTA 110 110 26 75
QUINAPRIL HCL 109 109 27 131
FENTANYL 109 97 S2 27 57
GABAPENTIN 109 101 27 18
TAMSULOSIN HCL 108 99 30 27
DIOVAN 103 88 31 38
MIRTAZAPINE 101 91 32 35
ALENDRONATE SODIUM 101 101 32 20
CARVEDILOL 101 93 32 30
ZOLPIDEM TARTRATE 100 67 35 25
KLOR-CON M20 98 98 36 71
ADVAIR DISKUS 93 84 37 31
PREDNISONE 91 91 38 32
RANITIDINE HCL 88 88 39 42
DIVALPROEX SODIUM 88 88 39 85
DIGOXIN 83 83 41 39
PANTOPRAZOLE SODIUM 82 81 42 34
POLYETHYLENE GLYCOL 3350 81 74 43 41
ATENOLOL 77 73 44 11
SPIRIVA 75 75 45 65
EXELON 75 75 45 149
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 65 47 29
LANTUS 70 70 48 46
CLOPIDOGREL 68 59 49 36
CLONIDINE HCL 68 66 49 67
LIDODERM 64 64 51 73
METFORMIN HCL ER 63 62 52 49
SPIRONOLACTONE 61 60 53 44
LANTUS SOLOSTAR 59 56 54 61
FLUTICASONE PROPIONATE 58 56 55 40
CARBIDOPA-LEVODOPA 58 58 55 77
CHLORTHALIDONE 54 54 57 119
LYRICA 53 37 58 114
VENLAFAXINE HCL ER 52 50 59 84
BYSTOLIC 52 52 59 123
PROAIR HFA 51 32 61 56
ENALAPRIL MALEATE 50 45 62 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.